Status:
COMPLETED
Assessment of Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure Without Androgen Deprivation Therapy
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
Among all the patients who underwent PET/CT with choline at our Institute between 2004 and 2007 to restage the prostatic disease following biochemical recovery of the disease, in this retrospective st...
Eligibility Criteria
Inclusion
- patients previously treated with radical prostatectomy, with progressive increase in PSA value in the absence of hormonal therapy.
Exclusion
- \< 18 years patients
Key Trial Info
Start Date :
June 19 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 15 2014
Estimated Enrollment :
302 Patients enrolled
Trial Details
Trial ID
NCT06167824
Start Date
June 19 2014
End Date
July 15 2014
Last Update
December 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Irccs San Raffaele
Milan, Italia, Italy